Closure of Trading Window for the quarter ending September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Godavari Drugs has informed BSE that the trading window for its designated persons and their immediate relatives will be closed from October 1, 2025, until 48 hours after the company declares its unaudited financial results for the half-year ended September 30, 2025. This is a routine compliance requirement under SEBI's Insider Trading Regulations, 2015, and applies to insiders who may have access to unpublished price-sensitive information. The board meeting date to approve the H1 FY26 results has not yet been announced and will be communicated separately. No insider trades or changes in shareholding are reported in this filing.
This is a standard regulatory notice and does not affect shareholders directly. It signals that the company's H1 FY26 results are expected soon, which could be a near-term catalyst for the stock once announced.